# HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

> **NCT04571619** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 643 (actual)

## Conditions studied

- End Stage Renal Disease
- Chronic Pain
- Opioid Dependence

## Interventions

- **BEHAVIORAL:** Pain Coping Skills Training (PCST)
- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT04571619
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-03
- **Primary completion:** 2023-12-21
- **Final completion:** 2024-05-31
- **Target enrollment:** 643 (ACTUAL)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04571619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04571619, "HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04571619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*